JP2024505923A - Ａｌアミロイドーシスを処置する方法 - Google Patents

Ａｌアミロイドーシスを処置する方法 Download PDF

Info

Publication number
JP2024505923A
JP2024505923A JP2023546007A JP2023546007A JP2024505923A JP 2024505923 A JP2024505923 A JP 2024505923A JP 2023546007 A JP2023546007 A JP 2023546007A JP 2023546007 A JP2023546007 A JP 2023546007A JP 2024505923 A JP2024505923 A JP 2024505923A
Authority
JP
Japan
Prior art keywords
meters
patient
treatment
months
pta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023546007A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022162625A5 (https=
JP2024505923A5 (https=
Inventor
ジーン キニー，
ワーグナー ザーゴ，
ラディカ トリプラネニ，
キャロル カープ，
Original Assignee
プロシーナ バイオサイエンシーズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プロシーナ バイオサイエンシーズ リミテッド filed Critical プロシーナ バイオサイエンシーズ リミテッド
Publication of JP2024505923A publication Critical patent/JP2024505923A/ja
Publication of JPWO2022162625A5 publication Critical patent/JPWO2022162625A5/ja
Publication of JP2024505923A5 publication Critical patent/JP2024505923A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
JP2023546007A 2021-01-29 2022-01-29 Ａｌアミロイドーシスを処置する方法 Pending JP2024505923A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
US63/143,728 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (3)

Publication Number Publication Date
JP2024505923A true JP2024505923A (ja) 2024-02-08
JPWO2022162625A5 JPWO2022162625A5 (https=) 2025-02-06
JP2024505923A5 JP2024505923A5 (https=) 2025-02-06

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546007A Pending JP2024505923A (ja) 2021-01-29 2022-01-29 Ａｌアミロイドーシスを処置する方法

Country Status (13)

Country Link
US (1) US20250084153A1 (https=)
EP (1) EP4284829A1 (https=)
JP (1) JP2024505923A (https=)
KR (1) KR20230136643A (https=)
CN (1) CN117098775A (https=)
AU (1) AU2022213010A1 (https=)
CA (1) CA3206326A1 (https=)
CL (1) CL2023002236A1 (https=)
IL (1) IL304755A (https=)
JO (1) JOP20230172A1 (https=)
MX (1) MX2023008835A (https=)
TW (1) TW202332465A (https=)
WO (1) WO2022162625A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552135A1 (en) 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019519584A (ja) * 2016-06-30 2019-07-11 プロシーナ バイオサイエンシーズ リミテッド アミロイドーシスを処置するための組成物
WO2020178638A1 (en) * 2019-03-05 2020-09-10 Prothena Biosciences Limited Methods of treating al amyloidosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019519584A (ja) * 2016-06-30 2019-07-11 プロシーナ バイオサイエンシーズ リミテッド アミロイドーシスを処置するための組成物
WO2020178638A1 (en) * 2019-03-05 2020-09-10 Prothena Biosciences Limited Methods of treating al amyloidosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BLOOD, vol. 134 (Supplement_1), JPN6025047633, 2019, pages 3166, ISSN: 0005735492 *

Also Published As

Publication number Publication date
US20250084153A1 (en) 2025-03-13
EP4284829A1 (en) 2023-12-06
JOP20230172A1 (ar) 2023-07-27
KR20230136643A (ko) 2023-09-26
IL304755A (en) 2023-09-01
CL2023002236A1 (es) 2024-02-09
CN117098775A (zh) 2023-11-21
AU2022213010A1 (en) 2023-08-17
WO2022162625A1 (en) 2022-08-04
AU2022213010A9 (en) 2024-09-26
TW202332465A (zh) 2023-08-16
CA3206326A1 (en) 2022-08-04
MX2023008835A (es) 2023-09-08

Similar Documents

Publication Publication Date Title
JP7619953B2 (ja) Ａｌアミロイドーシスを処置する方法
JP2024127990A (ja) アミロイドーシスを処置するための組成物
WO2022093841A1 (en) Anti-galectin-9 antibodies and uses thereof in the treatment of ocular melanoma
JP2024505923A (ja) Ａｌアミロイドーシスを処置する方法
JP2025502173A (ja) Ａｌアミロイドーシスを処置する方法
WO2025170969A1 (en) Methods of treating al amyloidosis
HK40066935A (en) An antibody for use in methods of treating al amyloidosis
HK40066935B (en) An antibody for use in methods of treating al amyloidosis
EA048260B1 (ru) Способы лечения al-амилоидоза

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250129

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250129

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251120